Bioanalysis of HIV protease inhibitors in samples from sanctuary sites
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 38 (1) , 139-147
- https://doi.org/10.1016/j.jpba.2004.12.012
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individualsAIDS, 2003
- Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2003
- AtazanavirDrugs, 2003
- Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2003
- Intracellular Concentration of Protease Inhibitors in HIV-1--Infected Patients: Correlation with MDR-1 Gene Expression and Low Dose of RitonavirHIV Research & Clinical Practice, 2002
- The Challenge of Viral Reservoirs in HIV-1 InfectionAnnual Review of Medicine, 2002
- Pharmacokinetic Profiles of Nevirapine and Indinavir in Various Fractions of Seminal PlasmaAntimicrobial Agents and Chemotherapy, 2001
- Antiretroviral drug concentrations in semen of HIV-1 infected menSexually Transmitted Infections, 2001
- Rapid and Simple Determination of Indinavir in Serum, Urine, and Cerebrospinal Fluid Using High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 2000
- Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patientsAIDS, 1997